Rockwell Medical (RMTI) Equity Average (2011 - 2026)

Rockwell Medical has reported Equity Average for 16 years, with the latest figure at $36.4 million in Q1 2026.

• For the quarter ending Q1 2026, Equity Average rose 13.62% year-over-year to $36.4 million; the trailing twelve-month figure through Mar 2026 stood at $36.4 million (up 13.62% YoY), and the FY2025 full-year result was $34.8 million, up 29.12% from the prior year.
• Equity Average for Q1 2026 stood at $36.4 million, down from $37.0 million in the prior quarter.
• The five-year high for Equity Average was $37.0 million in Q4 2025, with the low at -$1.1 million in Q1 2022.
• Historically, Equity Average has averaged $21.8 million across 5 years, with a median of $21.4 million in 2023.
• Annual changes were most pronounced in 2022 — Equity Average sank 103.76% — and 2023, when it soared 1272.89%.
• Rockwell Medical's Equity Average stood at $15.1 million in 2022, then jumped by 41.55% to $21.4 million in 2023, then soared by 44.18% to $30.9 million in 2024, then rose by 19.9% to $37.0 million in 2025, then slipped by 1.57% to $36.4 million in 2026.
• The last three Equity Average figures came in at $36.4 million (Q1 2026), $37.0 million (Q4 2025), and $33.7 million (Q3 2025), per Business Quant data.